Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    CLBH589BUS48T
Show Display Options
Rank Status Study
1 Completed Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
Condition: Mantle Cell Lymphoma
Interventions: Drug: Panobinostat;   Drug: Bortezomib

Study has passed its completion date and status has not been verified in more than two years.